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SUMMARY
Hedgehog (HH) proteins are proteolytically processed into a biologically active form, which is 
covalently modified by cholesterol and palmitate. However, most studies of HH biogenesis have 
characterized protein from cells in which HH is over-expressed. We purified Sonic Hedgehog 
(SHH) from cells expressing physiologically relevant levels, and showed that it was more potent 
than SHH isolated from over-expressing cells. Furthermore, the SHH in our preparations were 
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modified with a diverse spectrum of fatty acids on their amino-termini, and this spectrum of fatty 
acids varied dramatically depending on the growth conditions of the cells. The fatty acid 
composition of SHH affected its trafficking to lipid rafts, as well as its potency. Our results 
suggest that HH proteins exist as a family of diverse lipid-speciated proteins, which might be 
altered in different physiological and pathological contexts to regulate distinct properties of HH 
proteins.
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INTRODUCTION
The Hedgehog (HH) family of proteins play diverse biological roles that are conserved 
across different classes of animals (Ingham and McMahon, 2001). HH ligands are 
responsible for embryonic patterning as well as the maintenance, growth and renewal of 
various adult structures (Beachy et al., 2004; Ingham and McMahon, 2001). HH proteins 
harboring missense mutations have also been implicated in human developmental disorders 
(Bale, 2002), and reactivation of their expression is required for the viability of many 
cancers (Teglund and Toftgard, 2010). Biochemically, the most extensively studied HH 
protein is Sonic HH (SHH) (Farzan et al., 2008), which is produced as a ~45-kDa pre-pro-
protein that contains an amino-terminal signal sequence targeting SHH to the secretory 
pathway (Chang et al., 1994; Echelard et al., 1993; Krauss et al., 1993; Riddle et al., 1993; 
Roelink et al., 1994). During SHH's intracellular trafficking this signal sequence is cleaved 
off (Bumcrot et al., 1995). A sixteen carbon fatty acid, palmitate (C16:0), was reported to 
modify this newly exposed amino-terminal cysteine via a stable amide bond (Pepinsky et al., 
1998), in a reaction catalyzed by the SHH acyltransferase Skinny Hedgehog (Buglino and 
Resh, 2008; Chamoun et al., 2001). Although this palmitoylated, full-length form of SHH 
has substantial activity (Tokhunts et al., 2010), the bulk of SHH undergoes additional 
processing to yield a ~24 kDa amino-terminal form (Chang et al., 1994; Lopez-Martinez et 
al., 1995; Marti et al., 1995; Roelink et al., 1995). This latter processing step occurs in an 
intramolecular fashion, and results in the addition of cholesterol to the newly exposed 
carboxyl-terminal glycine via a labile ester bond (SHH-Np) (Lee, 1995; Lee et al., 1994; 
Porter et al., 1995).
Very little data regarding the biogenesis of endogenous HH proteins has been published, 
likely because of the scarcity of endogenous HH proteins and the difficulty of purifying and 
analyzing such hydrophobic proteins. What is known about the biogenesis of HH proteins is 
derived from studies where HH has been purified from cells engineered to vastly 
overexpress it (Pepinsky et al., 1998; Porter et al., 1996; Taipale et al., 2000), or from the 
analyses of recombinant HH proteins that lack their hydrophobic modifications (Lee et al., 
1994; Pathi et al., 2001; Taylor et al., 2001). Here, we describe the purification of a potent 
form of SHH-Np from cells that express endogenous-like levels of SHH. Further, we show 
that this purified SHH-Np actually consists of a family of proteins modified at its amino-
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terminus by a diverse spectrum of saturated and unsaturated fatty acids, and that these novel 
modifications dictate the biology of HH proteins.
EXPEIRMENTAL PROCEDURES
Comparison of SHH-Np levels
Fertile, certified research grade, pathogen free eggs (Charles River) were incubated at 37.5° 
C. At Hamburger-Hamilton (H&H) developmental stage 22, embryos were isolated and limb 
buds resected as previously described (Zeng et al., 2001). Resected buds were further 
divided into SHH producing posterior and SHH negative anterior portions, and lysed by 
suspending in 1% Tx-100, 10 mM sodium phosphate, 150 mM NaCl buffer, pH 7.4, 
supplemented with protease inhibitors (Roche). Immunoblotting was performed using anti 
SHH-Np polyclonal H-160 antibodies (Santa-Cruz).
Purification of SHH-Np
SHH-I cells (Taipale et al., 2000) were washed with PBS, collected by scraping, dounce 
homogenized, and centrifuged at 100,000 × g for 1 hr. The resultant pellet was resuspended 
in buffer A, recentrifuged, and the membrane enriched pellet extracted twice with buffer B 
by dounce homogenization and centrifugation at 16,000 × g for 30 min. The supernatants 
were combined, pH adjusted to 5.0 with 1 M MES, and applied to a bulk SP Sepharose Fast 
Flow resin. This resin was washed once with buffer C, followed by a second wash with 
buffer D. SHH-Np was eluted from this resin using buffer E. The eluted fractions were 
adjusted to pH 7.2 with 1 M HEPES, and then passed through a 5E1 monoclonal antibody 
(mAb) column (Ericson et al., 1996). After washing the column with buffer F the SHH-Np 
was eluted with buffer G, and then immediately neutralized with 1 M HEPES, pH 7.4. 
Please refer to the Supplementary Materials for details of buffers A-G.
Purified SHH-Np was quantified after SDS-PAGE, comparing its concentration against a 
standard curve of recombinant SHH-II (R&D). This gel was subsequently protein stained 
using a SilverQuest staining kit (Invitrogen). The optical density of each stained protein was 
then calculated and compared using Image J software (NIH). SHH activity measurements 
were performed essentially as described, using NIH-3T3 cells expressing a HH reporter gene 
(Light-II cells) (Singh et al., 2009). SHH-Np dependent differentiation and gene expression 
were assayed using C3H10T1/2 cell line as previously described (Zeng et al., 2001). All 
activity measurements were done in triplicate, and each experiment was repeated at least 
three times. The activity data presented is shown as the mean and the standard deviation 
(SD) of one representative experiment.
Mass Spectrometry Analyses
The identity of the purified SHH-Np was validated using microcapillary LC/MS on a 
ThermoFinnigan LTQ ion trap mass spectrometer. For identification of fatty acid 
modifications, SHH-Np was reduced with 4 mM DTT, alkylated with 15 mM 
iodoacetamide, and EndoLysC digested. Lipid modified peptides were identified by tandem 
mass spectrometry analysis on a LTQ-Orbitrap (Thermo) interfaced with an Eksigent 
nanoLC-2D HPLC. Tandem mass spectra (MS/MS) were searched against the SHH protein 
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sequence using a Mascot (v 2.1) error tolerant search with 20 ppm parent mass accuracy, 
and Inspect/MS-Alignment run in blind modification search mode (Tanner et al., 2006). All 
MS/MS spectra peptide assignments were manually verified for peptide assignments.
Lipid treatments
SHH-I cells were serum deprived for 6-7 hrs in 0.5% FBS. Prior to lipid treatment the cells 
were washed with PBS once, and then maintained in the presence of 100 μM fatty acids or 
DMSO (vehicle) for 16-18 hrs (Liang et al., 2001). For embryonic tissue studies, 10-12 
pathogen free Hamburger-Hamilton (H&H) developmental stage 22 chick embryos (Charles 
River) were collected (Zeng et al., 2001), and posterior fragments of the limb buds dissected 
as previously described (Zeng et al., 2001). These posterior tissues were incubated with 100 
μM fatty acids or DMSO (vehicle) for 16-18 hrs in 6 well plates. These tissues were 
subsequently washed twice in ice cold PBS and homogenized in a 1% Tx-100, 10 mM 
sodium phosphate,150 mM NaCl buffer, pH 6.5.
OptiPrep density gradient ultracentrifugation
Cell or tissue extract was mixed with OptiPrep medium to obtain a 40% fraction. Then two 
other fractions, composed of 25% and 10% OptiPrep medium or 30% and 0% for tissue 
extract, sequentially layered on top followed by centrifugation at 120,000 × g, or 160,000 × 
g for tissue extract, for 21 hrs (Bruses et al., 2001; Chen et al., 2004; Lisanti et al., 1994). 
Fractions from the tubes were collected and subjected to SDS-PAGE analysis.
RESULTS
To identify a cell-line expressing low levels of SHH, we first compared the steady-state 
levels of SHH-Np for a previously described cell line (SHH-I cells) that expresses SHH 
under control of a muristerone inducible promoter (Taipale et al., 2000) (Fig. 1A and Fig 
S1A). SHH-I cells produced low levels of SHH-Np in the absence of induction, presumably 
due to the promiscuity of such inducible promoters, and these levels increased 
approximately twenty-fold in the presence of muristerone. We next compared the activity of 
SHH-Np from cell lysates obtained with or without muristerone treatment, measuring the 
ability of similar amounts of SHH-Np to activate an engineered SHH reporter cell line 
(Light-II cells) driving Firefly luciferase expression (Taipale et al., 2000) (Fig. 1B and Fig 
S1B). The normalized potency of SHH-Np produced under uninduced conditions was 
significantly higher than that produced when its expression was induced by muristerone. To 
compare the levels of SHH-Np produced by SHH-I cells to that produced in a 
physiologically relevant setting (Riddle et al., 1993), we compared the steady-state levels of 
SHH-Np from uninduced SHH-I cells to dissected posterior and anterior halves of chick 
limb buds (Fig. 1C). SHH-Np levels were similar for uninduced SHH-I cells and posterior 
chick limb bud tissue.
Using published purification protocols (Pepinsky et al., 1998; Taipale et al., 2000) we were 
unable to purify SHH-Np from uninduced SHH-I cells expressing such low-levels of SHH. 
Thus, we modified these procedures to maximize the yield of active SHH-Np from such 
cells. Uninduced SHH-I cells were dounce homogenized in an isotonic, detergent free buffer 
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(Fig. 2A) to obtain a total lysate. This cellular lysate was further fractionated by 
centrifugation at 100,000 × g, producing cytoplasmic and membrane enriched fractions. 
Similarly prepared lysates of SHH-I parental cells, which do not express detectable amounts 
of SHH were used as a negative control. The bulk of SHH-Np was in the membrane fraction, 
consistent with previous reports (Taipale et al., 2000). Aliquots of these lysates, along with 
the cytoplasmic or membrane enriched fractions of these cells, were volume normalized then 
incubated with Light-II cells to estimate the levels of active SHH in each fraction (data not 
shown). The bulk of SHH activity was also found in the membrane enriched pellet.
Detergent extraction of the membrane fraction and purification by centrifugation, ion 
exchange chromatography and affinity chromatography (see Supplementary Experimental 
Procedures) resulted in 5 ng of purified SHH-Np per mg of total cellular lysate (Fig. 2B). 
We estimate the purity of this preparation to be greater than 95%, representing a 200,000-
fold purification. The identity of the purified SHH-Np was confirmed by tandem mass 
spectrometry (data not shown). The vast majority of recovered peptides were derived from 
the amino-terminal domain of SHH, with a coverage against the predicted amino-acid 
sequence of SHH-N approaching 90%. To compare the potency of the SHH-Np isolated 
here to those previously described (Pathi et al., 2001; Pepinsky et al., 1998; Taipale et al., 
2000) we assayed the differentiation of C3H10T1/2 embryonic fibroblasts into osteoblasts 
(Kinto et al., 1997). The EC50 of SHH-Np purified from uninduced SHH-I cells was 0.3 nM, 
while the EC50 of recombinant SHH-N was 60 nM (Fig. 2C). We also quantified the 
expression of the SHH target gene Gli1 as an indicator of activity (Ingram et al., 2002), 
treating C3H10T1/2 cells with purified SHH-Np (Fig. 2D). From this analysis we estimated 
the EC50 of purified SHH-Np to be 0.2 nM. In both of these assays the potency of SHH-Np 
was significantly greater than previously reported (Pathi et al., 2001; Pepinsky et al., 1998; 
Taipale et al., 2000). Purified SHH-Np was also able to stimulate the proliferation of 
primary cerebellar granular neuron precursor cells (GPC) (Dahmane and Ruiz i Altaba, 
1999), confirming its activity (Fig. S2). Thus, our SHH-Np purification protocol isolates 
biologically active, potent SHH-Np, from cells expressing endogenous-like levels of SHH.
We speculated that the increased potency of SHH-Np purified from uninduced SHH-Np 
cells might result from differential amino-terminal fatty acid modifications, which can alter 
the activity of recombinant SHH-N in vitro (Pathi et al., 2001; Taylor et al., 2001). To 
investigate this possibility we analyzed Lys-C digested, purified SHH-Np by LC-MS/MS 
using a high-resolution LTQ Orbitrap mass spectrometer. The mass/charge ratios obtained 
during these analyses were cross-referenced against expected unmodified masses of 
individual peptides, and the MS/MS of modified forms validated manually (Table S1 and 
Fig. S3A-C). Contrary to previous reports (Pepinsky et al., 1998; Taipale et al., 2000), we 
identified a diverse assortment of saturated and unsaturated fatty acid modifications on 
SHH-Np. Based on extracted ion chromatogram (XIC) peak areas, the most abundant fatty 
acid-modified forms of SHH-Np were modified with palmitate (C16:0), a palmitoleoyl 
(C16:1), followed by a stearoleyl (C18:1), a myristoleyl (C14:1), and then to a lesser degree, 
a stearoyl (C18:0) and myristoyl (C14:0) groups. A number of amino-terminal peptides 
showed masses encompassing as yet undetermined modifications, consistent with SHH-Np 
being modified by a diversity of lipid species.
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To extend these findings we also purified SHH-Np from SHH-I cells induced to express 
higher levels of SHH: 1) in the presence of 10% FBS, 2) in the presence serum free media, 
and 3) in the presence of serum free media supplemented with myristate (C14:0). The 
pattern of lipid speciation on SHH-Np changed significantly under all of these conditions, 
suggesting that the lipid speciation of SHH is very sensitive to cellular context (Fig. 3). We 
noted that unsaturated fatty acid modified SHH-Np is the dominant species regardless of the 
cellular context, whereas the abundance of SHH-Np forms modified with saturated fatty 
acids were significantly more variable. Interestingly, the fatty acid modifications on SHH-
Np isolated from cells expressing high levels of SHH, grown in FBS, approximately 
mirrored the abundance of fatty acids found in the membranes of cells grown in FBS, 
whereas the lipid speciated forms of SHH-Np purified from cells grown under the other 
conditions did not. We further noted that SHH-Np isolated from cells grown under serum 
free conditions but supplemented with myristate (C14:0) showed an ~500% increase of 
myristate modified SHH-Np (data not shown), consistent with us being able to 
experimentally manipulate the fatty acid speciation of SHH-Np. Significantly, we did not 
detect an amino-terminal peptide lacking fatty acid modifications in these experiments. 
Although MS is not generally quantitative, the abundance of the same peptide in different 
samples may be quantitatively compared (Old et al., 2005). Therefore, the absence of an 
unmodified amino-terminal peptide in our extracted chromatograms suggests that SHH-Np 
is quantitatively modified by fatty acids in these cells.
The hydrophobic properties of the various fatty acid modifications we observed on SHH-Np 
vary over a 500-fold range (Table S1), suggesting that they would alter the biological 
properties of SHH-Np. Further, unsaturated fatty acids, such as those found on SHH-Np, are 
known to segregate away from lipid rafts (Levental et al., 2010), where HH proteins are 
thought to enrich as part of its regulated intracellular movement (Callejo et al., 2011; 
Creanga et al., 2012; Mao et al., 2009; Rietveld et al., 1999; Taipale et al., 2000). To test this 
hypothesis, we altered the fatty acid composition of media used with cells or chick limb bud 
explants expressing SHH, and then measured various properties of the resulting SHH-Np. 
Such lipid doping experiments have previously been used to alter the covalent lipid 
modifications of numerous proteins (Hashimoto et al., 2004; Liang et al., 2001; Wolven et 
al., 1997), prior to determining their changes in biological function. We therefore incubated 
serum-deprived SHH-I cells with saturated C14:0, C16:0, C18:0, or unsaturated C16:1 fatty 
acids, and examined the levels of SHH-Np in both cell lysates and secreted from those cells 
into conditioned media. While we did not observe changes in the absolute levels of cell 
associated SHH-Np when cells were doped with different fatty acids, consistent with 
previous reports (Bumcrot et al., 1995), we did observe differences in the secretion of SHH-
Np forms from cells incubated with different fatty acids (Fig. 4A).
Because lipid raft localization is thought to be a prerequisite for the secretion of HH proteins 
(Callejo et al., 2011; Creanga et al., 2012; Rietveld et al., 1999), we asked whether the 
various fatty acid modified SHH-Np forms would differentially localize to lipid rafts. The 
cellular lysates of cells incubated with various fatty acids were therefore fractionated over an 
OptiPrep gradient to isolate lipid raft enriched fractions (Fig. 4B, and data not shown). 
Incubation of uninduced SHH-I cells with any of the tested saturated fatty acids (C14:0, 
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C16:0 or C18:0) increased the percentage of SHH-Np enriched in lipid rafts (Fig. 4C). In 
contrast, incubation of SHH-I cells with palmitoleate (C16:1) reduced the percentage of 
SHH-Np enriched in lipid rafts. Similar experiments were performed on anterior or posterior 
chick limb bud explants. Consistent with our SHH-I cell based observations, treatment of the 
explants with unsaturated C16:1 resulted in decreased SHH-Np localization to lipid rafts in 
posterior tissue (Fig. 5A). While incubation of tissue explants with saturated fatty acids had 
no effect on steady-state SHH-Np levels, increased levels of tissue SHH-Np were observed 
upon palmitoleoyl (C16:1) incubation. The mRNA levels of SHH were unchanged by 
different fatty acid incubation (data not shown). These results are consistent with decreased 
secretion of palmitoleoyl (C16:1) modified SHH-Np, resulting in increased retention in 
posterior limb bud tissue. We further measured the activity of SHH-Np from these tissues 
and normalized this activity to their relative abundance (Fig. 5B and Fig. 5C). This analysis 
showed that incubation of posterior limb bud fragments with C16:1 reduced SHH-Np 
activity.
DISCUSSION
We now demonstrate that SHH-Np is actually a family of distinct lipid speciated forms, 
which exhibit a variety of differential properties. Thus we favor the idea that modification of 
SHH-Np by a spectrum of fatty acids provides another biologically relevant layer of SHH-
Np regulation. Although the spectrum of fatty acid modifications on SHH-Np was not 
initially described, a similar spectrum of modifications for a small percentage of the SHH 
mutant SHH-N, which is a non-physiologically relevant form of SHH that is not cholesterol 
modified, was described (Pepinsky et al., 1998). We speculate that differences in 
purification protocols or levels of expression resulted in the identification of only the most 
abundant, palmitoyl-modified form of SHH-Np in these previous reports. For example, one 
of the previous purification protocols for SHH-Np started with a lipid raft enriched fraction 
(Taipale et al., 2000) , which based on our data might exclude SHH-Np modified by 
unsaturated fatty acids. How such differential forms of SHH-Np might arise is also not yet 
clear. However, in vitro, Skinny Hedgehog is able to utilize a wide spectrum of fatty acids, 
many of which have a higher affinity for Skinny Hedgehog than palmitate (Buglino and 
Resh, 2008). Interestingly, the potency of recombinant forms of SHH-N is altered when it is 
modified by different fatty acids in vitro (Taylor et al., 2001). This observation is consistent 
with Skinny Hedgehog being sufficient to modify SHH with the diverse spectrum of fatty 
acids described here.
Our findings suggest that one consequence of SHH-Np's fatty acid speciation is the 
regulation of its intracellular trafficking, with decreased localization of SHH-Np modified 
with unsaturated fatty acids to lipid rafts. This decreased localization is likely the result of 
unsaturated fatty acids lacking the compactness required to enrich in lipid raft compartments 
of cellular membranes (Levental et al., 2010), although such fatty acid doping experiments 
likely result in the production of a number of different fatty acylated species. However, a 
simple differential localization of SHH-Np proteins to the lipid raft or non-lipid raft 
compartments of cellular membranes could arise solely by regulating the degree of fatty acid 
saturation on SHH-Np. One observed functional consequence of this differential localization 
is the secretion of lipid raft localized SHH-Np forms and retention of raft excluded forms. 
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Such SHH-Np speciation might then contribute to the gradient of SHH-Np observed in vivo 
(Gritli-Linde et al., 2001), with SHH-Np modified with the least hydrophobic fatty acids 
moving further away from the SHH producing cells than SHH-Np family members modified 
with more hydrophobic fatty acids. In such a scenario, different fatty acid modifications 
might modulate SHH-Np's affinity for the various lipoprotein complexes suggested to 
regulate the movement of HH proteins (Callejo et al., 2008; Gradilla et al., 2014; Guerrero 
and Chiang, 2007; Matusek et al., 2014; Palm et al., 2013; Therond, 2012; Zeng et al., 
2001). Alternatively, fatty acid speciation of SHH-Np might alter its targeting “barcode” 
(Kornberg, 2011), allowing it to associate with diverse types of lipid microdomains enriched 
on the cytonemes responsible for HH movement (Fifadara et al., 2010; Gupta and DeFranco, 
2003; Kornberg, 2013; Sanders et al., 2013). In either model, the fatty acid speciation of 
SHH described here might be utilized to encode dramatic changes in cellular growth and 
metabolism, such as those occurring during early development or cancer, directly into the 
HH proteins regulating these biological processes.
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Figure 1. SHH-I cells produce endogenous-like levels of potent SHH-Np
(A) An immunoblot showing SHH-Np abundance in SHH-I cells, under conditions in which 
its expression was induced (+) or uninduced (−) with muristerone. SHH-I parental cells, 
which are not engineered to express SHH, were used as a control (Ctrl). GAPDH was used 
to verify protein normalization. (B) An aliquot of SHH-I cellular lysate was tested for SHH-
Np associated activity using the Light-II reporter cell line. SHH-Np activity measurements 
were carried out in the linear range of this assay (see Figure S1B), and these activity results 
were then normalized to overall SHH-Np levels to determine potency. Error bars represent 
the standard deviation (SD) in one representative experiment. (C) SHH-Np levels from 
uninduced SHH-I cells and chick embryo limb buds were compared by immunoblotting. 
During development SHH-Np is produced in the posterior portion of limb buds (Post). Here, 
the anterior (Ant) portion of limb buds serves as a negative control for SHH-Np. As only 
approximately 20% of the posterior tissue consists of SHH producing cells (Riddle et al., 
1993), we mixed 20% of SHH-I cell lysate with 80% of lysate from anterior limb bud tissue 
for this comparison. GAPDH was used to verify normalization.
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Figure 2. SHH-Np purified from low-level SHH expressing cells is highly active
(A) SHH-I cells, or the SHH-I parental cell line (Ctrl), were dounce homogenized under 
isotonic conditions and total lysate (left panel) separated by ultracentrifugation at 100,000 × 
g (right panel) to generate a cytosol-enriched fraction (Cyt) and a membrane-enriched 
fraction (Mem). These fractions were volume normalized to that of the original cellular 
lysate and immunoblotted as indicated. Tubulin serves as a cytosolic protein control while 
the Na+/K+ transporter serves as a membrane protein control. (B) Aliquots of the indicated 
fractions from various steps of SHH-Np purification were separated by SDS-PAGE, 
followed by visualization of proteins by silver staining (TL: total lysate, S: 100,000 × g 
supernatant, M: combined 100,000 × g pellet detergent extract, FT: non-bound material, W: 
column wash, E: column eluate). Recombinant, unmodified, SHH-N is shown as a control 
(rSHH-N). Electrophoretic retardation of rSHH-N, relative to cholesterol modified SHH-Np, 
has been previously noted (Lee et al., 1994). (C) The indicated amounts of purified SHH-Np 
were incubated with C3H10T1/2 fibroblasts, which differentiate into osteoblasts in response 
to SHH (squares: purified SHH-Np, circles: rSHH-N). Alkaline phosphatase activity, which 
is an indirect, quantitative measurement of this differentiation, was then measured. (D) The 
indicated amounts of purified SHH-Np were incubated with C3H10T1/2 fibroblasts, 
followed by RNA extraction. The levels of Gli1 and GAPDH were then determined by q-
RT-PCR. Error bars represent the SD in one representative experiment.
Long et al. Page 14
Cell Rep. Author manuscript; available in PMC 2016 March 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Fatty acid speciation of SHH-Np is cell context dependent
(A): A schematic showing the procedure used to identify the fatty acid modification on 
SHH-Np. (B-D): Pie charts showing the relative abundance of lipid species identified on 
SHH-Np purified isolated under three different cell contexts: 10% FBS without muristerone 
induction of SHH expression , 10% FBS and muristerone induction of SHH expression, and 
serum deprivation and muristerone induction of SHH expression.
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Figure 4. Fatty acid speciation of SHH-Np alters its lipid raft enrichment
(A) An immunoblot of cell lysates and conditioned media, from SHH-I cells incubated in the 
presence of indicated fatty acids. GAPDH served as a normalization control for cellular 
lysates. The same volume of conditioned medium was subjected to TCA precipitation prior 
to loading. (B) Lysates from SHH-I cells incubated with the indicated lipids, or DMSO 
control, were separated over an OptiPrep gradient to isolate a lipid raft enriched fraction. 
Fractions from these various OptiPrep density gradients were resolved by SDS-PAGE then 
analyzed by immunoblotting for SHH-Np, GAPDH as a cytoplasmic protein marker, or the 
lipid raft marker flotillin. Note that flotillin localization does not change with various lipid 
additions. Quantification of SHH-Np lipid raft enrichment from cells incubated with the 
indicated fatty acids is shown in (C). Error bars represent the standard error of the mean 
(SEM) of three independent experiments. p values ≤ 0.05 are considered statistically 
significant, and indicated by a asterisk.
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Figure 5. Modification of SHH-Np with distinct fatty acids alters its functionality
(A) Lysates from embryonic limb bud explants exposed to different fatty acids were 
separated over an OptiPrep density gradient to isolate the lipid raft fraction. Various gradient 
fractions were resolved by SDS-PAGE than analyzed by immunoblotting for SHH-Np. 
Caveolin-1 was used as a lipid raft marker while GAPDH served to label non-lipid raft 
associated subcellular fractions. Treatment with saturated fatty acids did not change SHH-
Np localization pattern over the DMSO control (data not shown). (B) An immunoblot (upper 
panel) of limb bud lysates showing effect of lipid modifications on SHH-Np levels. Lysates 
contain similar amount of total protein as indicated by total protein silver staining (lower 
panel). (C) The potency of SHH-Np was determined by incubating lysate from treated limb 
buds with Light-II cells, and then normalizing this activity to SHH-Np levels. Error bars 
represent the SEM of three independent experiments. p values ≤ 0.05 are considered 
statistically significant, and indicated by an asterisk.
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